Trade Tricida, Inc. - TCDA shares price

Open on web platform

Market info

Min traded quantity:: 1
Full name:: Tricida, Inc.
Currency:: USD
Margin:: 5%
Stock exchange:: United States of America
Long position overnight fee: -0.0203%
Short position overnight fee: -0.0102%

Trading hours (UTC)

Tue - Fri:: 13:30 - 20:00

TCDA

Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). It has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.
White Paper Declaration

You might be interested in

BNTX

Biontech SE

Sell Buy

51.06

DDOG

Datadog Inc

Sell Buy

73.08

BRBR

BellRing Brands Inc

Sell Buy

19.44

9988

Alibaba Group Holding Limited

Sell Buy

195.9

Crypto as collateral

Trade the global financial markets using Bitcoin or Ethereum.

Security as priority

Authorised by the High Technology Park of Belarus, the European blockchain regulator, the safety of your holdings is guaranteed.

Technical indicators

Keep an eye on your positions with over 75 advanced charts, price analysis and price alerts.

Control your capital

Use stop-loss and take-profit orders to keep what you earn.

Use the world’s first regulated tokenised assets exchange to build a diverse investment portfolio with your crypto holdings. Make your deposits in Bitcoin or Ethereum to trade global financial instruments with competitive leverage and tight spreads. Currency.com keeps your holdings secure and accessible at a glance.